Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome

NCT01112683 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Down Syndrome

Interventions

DRUG: Memantine
DRUG: Placebo

Sponsor

University of Colorado, Denver

Collaborators

[object Object]